Lenovo backs Shenzhen exoskeleton maker Miles Robot for a fourth round

A state fund joins the cap table

Shenzhen Miles Robot has closed a new roughly 100 million yuan strategic round led by CICC, the state-backed investment bank, according to 36Kr. The capital accelerates product iteration, brain-computer-interface work and a hospital-to-community-to-home elderly-care push. Lenovo Capital has now invested in four consecutive rounds, alongside Taiyou Fund, Sihuan Pharma, Xingchen Fund, Dening and Shangshan.

Miles Robot was founded in 2016 by a returnee PhD team and builds medical-rehabilitation and daily-assist exoskeletons. Its new CEO Chen Kangning previously worked at Johnson and Johnson and brings experience across product registration and channel build-out. The company focuses on flexible-actuator human-machine interaction and a matrix spanning its H, A and C children’s lower-limb rehab lines, the 3000-Step wellness line and the daily MAX assist line.

The 3000-Step wellness series is light and portable enough for hospitals, communities, parks and homes, meant to build a daily 3,000-step habit and lower the barrier to rehab exercise. Miles holds more than 200 patents, its core products have Class II medical certification, and it has entered the market at volume.

A breakout category

Miles grew revenue nearly 200 per cent in 2025, with overseas contributing over a third. The sector is heating fast. IDC puts China’s 2025 exoskeleton market above 1.6 billion yuan and shipments around 26,000 units, with medical rehab dominating value and consumer assist driving over 70 per cent of shipments.

The Commerce Ministry says first-half domestic smart-exoskeleton demand rose 458.4 per cent year on year, and JD retail data shows transactions up more than 15,000 per cent over the same period. The National Healthcare Security Administration’s fifteenth five-year plan explicitly promotes smart exoskeletons in long-term care.

Policy, market and consumer demand are stacking at once, pulling exoskeletons from niche hardware into everyday elderly care. Shenzhen’s rehab-robot cluster is moving from clinic to consumer faster than the forecasts assumed.

Editor’s note: This is an adapted translation of the original OFweek report. It has been trimmed and restructured for readability for an international business audience. The full original (in Chinese) is at https://robot.ofweek.com/2026-08/ART-8321203-8120-30700672.html.

Leave a comment